{"title":"评估全身麻醉期间顺阿曲库铵的三种不同剂量:前瞻性随机研究。","authors":"Prashant Kumar, Jyoti Vats, Kiranpreet Kaur, Jyoti Sharma, Sanjay Johar","doi":"10.4103/joacp.joacp_253_22","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>The present study was conducted to determine the optimal dose of cisatracurium for intubating conditions and onset and offset of neuromuscular blockade. Data in Indian population are scarce, and hence, the present study was planned to evaluate different doses of cisatracurium.</p><p><strong>Material and methods: </strong>The prospective randomized double-blind study was conducted on 180 patients of either sex in the age group of 20-60 yrs., having physical status class I to III, scheduled for surgery under general anesthesia. After exclusion 154 patients were randomly divided into three groups comprising 52, 51, and 51, respectively, in Group A, Group B, and group C. They received 0.1 mgkg<sup>-1</sup>, 0.2 mgkg<sup>-1</sup>, and 0.3 mgkg<sup>-1</sup> of cisatracurium, respectively, to facilitate endotracheal intubation. Time of onset, intubating conditions, hemodynamic parameters, signs of histamine release, and recovery time were noted.</p><p><strong>Results: </strong>Mean time to onset was maximum in group A (4.37 ± 0.48 minutes) and minimum in group C (2.33 ± 0.43 minutes). Intubating conditions were found excellent in 88% patients in group. Change in HR was found to be non-significant at all time periods, but decrease in MAP was found between 2 and 10 minutes in group C. Duration of action was longest in group C.</p><p><strong>Conclusion: </strong>We conclude that cisatracurium in dose of 0.2 mgkg<sup>-1</sup> and 0.3 mgkg<sup>-1</sup> provides good-to-excellent intubating conditions within less than 3 minutes.</p>","PeriodicalId":14946,"journal":{"name":"Journal of Anaesthesiology, Clinical Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11042083/pdf/","citationCount":"0","resultStr":"{\"title\":\"Evaluation of the three different doses of cisatracurium during general anaesthesia: A prospective randomized study.\",\"authors\":\"Prashant Kumar, Jyoti Vats, Kiranpreet Kaur, Jyoti Sharma, Sanjay Johar\",\"doi\":\"10.4103/joacp.joacp_253_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and aims: </strong>The present study was conducted to determine the optimal dose of cisatracurium for intubating conditions and onset and offset of neuromuscular blockade. Data in Indian population are scarce, and hence, the present study was planned to evaluate different doses of cisatracurium.</p><p><strong>Material and methods: </strong>The prospective randomized double-blind study was conducted on 180 patients of either sex in the age group of 20-60 yrs., having physical status class I to III, scheduled for surgery under general anesthesia. After exclusion 154 patients were randomly divided into three groups comprising 52, 51, and 51, respectively, in Group A, Group B, and group C. They received 0.1 mgkg<sup>-1</sup>, 0.2 mgkg<sup>-1</sup>, and 0.3 mgkg<sup>-1</sup> of cisatracurium, respectively, to facilitate endotracheal intubation. Time of onset, intubating conditions, hemodynamic parameters, signs of histamine release, and recovery time were noted.</p><p><strong>Results: </strong>Mean time to onset was maximum in group A (4.37 ± 0.48 minutes) and minimum in group C (2.33 ± 0.43 minutes). Intubating conditions were found excellent in 88% patients in group. Change in HR was found to be non-significant at all time periods, but decrease in MAP was found between 2 and 10 minutes in group C. Duration of action was longest in group C.</p><p><strong>Conclusion: </strong>We conclude that cisatracurium in dose of 0.2 mgkg<sup>-1</sup> and 0.3 mgkg<sup>-1</sup> provides good-to-excellent intubating conditions within less than 3 minutes.</p>\",\"PeriodicalId\":14946,\"journal\":{\"name\":\"Journal of Anaesthesiology, Clinical Pharmacology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11042083/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Anaesthesiology, Clinical Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/joacp.joacp_253_22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Anaesthesiology, Clinical Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/joacp.joacp_253_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:本研究旨在确定顺阿曲库铵在插管条件下的最佳剂量以及神经肌肉阻滞的开始和结束。印度人群中的数据很少,因此,本研究计划对不同剂量的顺阿曲库铵进行评估:这项前瞻性随机双盲研究的对象是 180 名年龄在 20-60 岁之间、身体状况为 I 至 III 级、计划在全身麻醉下进行手术的男女患者。经排除后,154 名患者被随机分为三组,分别为 A 组 52 人、B 组 51 人和 C 组 51 人。他们分别接受了 0.1 毫克/公斤-1、0.2 毫克/公斤-1 和 0.3 毫克/公斤-1 的顺阿曲库铵,以促进气管插管。结果发现,顺阿曲库铵组的平均起效时间最长,而西阿曲库铵组的平均起效时间最短:结果:A 组的平均起始时间最长(4.37±0.48 分钟),C 组最短(2.33±0.43 分钟)。A组中88%的患者插管条件良好。所有时间段的心率变化均无显著性,但 C 组的 MAP 在 2 至 10 分钟之间有所下降:我们得出的结论是,0.2 毫克/千克和 0.3 毫克/千克剂量的顺阿曲库铵可在 3 分钟内提供良好至卓越的插管条件。
Evaluation of the three different doses of cisatracurium during general anaesthesia: A prospective randomized study.
Background and aims: The present study was conducted to determine the optimal dose of cisatracurium for intubating conditions and onset and offset of neuromuscular blockade. Data in Indian population are scarce, and hence, the present study was planned to evaluate different doses of cisatracurium.
Material and methods: The prospective randomized double-blind study was conducted on 180 patients of either sex in the age group of 20-60 yrs., having physical status class I to III, scheduled for surgery under general anesthesia. After exclusion 154 patients were randomly divided into three groups comprising 52, 51, and 51, respectively, in Group A, Group B, and group C. They received 0.1 mgkg-1, 0.2 mgkg-1, and 0.3 mgkg-1 of cisatracurium, respectively, to facilitate endotracheal intubation. Time of onset, intubating conditions, hemodynamic parameters, signs of histamine release, and recovery time were noted.
Results: Mean time to onset was maximum in group A (4.37 ± 0.48 minutes) and minimum in group C (2.33 ± 0.43 minutes). Intubating conditions were found excellent in 88% patients in group. Change in HR was found to be non-significant at all time periods, but decrease in MAP was found between 2 and 10 minutes in group C. Duration of action was longest in group C.
Conclusion: We conclude that cisatracurium in dose of 0.2 mgkg-1 and 0.3 mgkg-1 provides good-to-excellent intubating conditions within less than 3 minutes.
期刊介绍:
The JOACP publishes original peer-reviewed research and clinical work in all branches of anaesthesiology, pain, critical care and perioperative medicine including the application to basic sciences. In addition, the journal publishes review articles, special articles, brief communications/reports, case reports, and reports of new equipment, letters to editor, book reviews and obituaries. It is international in scope and comprehensive in coverage.